1. How Carl Icahn Won Big In Actavis' $25B Deal For Forest Labs

    How Carl Icahn Won Big In Actavis' $25B Deal For Forest Labs

    For more than four years, billionaire investor Carl Icahn made a huge bet on Forest Laboratories, agitating for change at the drug maker. With more than an 11% stake in the company, Forest Labs was Icahn’s biggest trading position going into 2013 and his second biggest trading position going into 2014—trailing only his bet on Apple. He is the company’s second-biggest shareholder...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. Activism, especially in biotech, usually takes longer than you believe it will.
    2. FOREST LABS IS NOT A DYNASTY TO BE DESPOTICALLY HANDED DOWN FROM FATHER TO SON IGNORING THE GREAT RISK OF THIS ACTION TO ITS SHAREHOLDERS.
    3. We believe that our activism did much to help bring about the great result announced today.
  3. Topics Mentioned

  4. Authors